NEW YORK: Hill & Knowlton appointed Daniel McIntyre as worldwide head of healthcare, effective May 17. Based in New York, he will be a member of H&K's global council and report to Paul Taaffe, chairman and global CEO.
McIntyre most recently was a partner at Global Prairie, an integrated marketing communications consultancy and served as head of communications at Wyeth prior to its acquisition by Pfizer. In his 30-year career in the industry, he also has held positions at Fleishman-Hillard, MeadWestvaco, Pharmacia, American Home Products, Hoffmann LaRoche, and Bayer.
He replaces AnnaMaria DeSalva, who left H&K in November 2009 to join Pfizer.
Taaffe said that in looking for DeSalva's replacement, he spoke to several clients about their healthcare PR needs and discovered that finding people well-versed in product communications was not their primary concern.
“They were telling me what they were missing was someone who knew where the category was going,” he said, adding that this included understanding such issues as market access, global regulatory oversight, and risk communications. “We want to help clients right across the board. Dan really does have that broad spectrum of experience.”
McIntyre said that he will build on the foundation of the practice, while trying to increase its presence in the US market.
“I'd like to expand on the offering right now in healthcare to meet the next generation of healthcare needs, recognizing the regulatory hurdles, social and economic hurdles, and policy aspects of doing business around the world,” he added.
According to Taaffe, healthcare is approximately an $80 million business for H&K globally. Some of its clients include Pfizer, J&J, Amgen, Merck, Forest Laboratories, Novartis, Roche, and Medtronic.